| Bioactivity | Bersiporocin is a prolyl-tRNA synthetase inhibitor. Bersiporocin has an IC50 of ≤100 nM for phosphoribosylpyrophosphate synthetase (PRS). Bersiporocin can be used for the research of antifibrotic[1][2]. |
| Name | Bersiporocin |
| CAS | 2241808-52-4 |
| Formula | C15H19Cl2N3O |
| Molar Mass | 328.24 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Bong-Yong Lee, et al. Heterocyclic compounds, preparation methods, pharmaceutical compositions, and use as pyrolyl-tRNA synthetase inhibitors.WO2018147626 A1 [2]. WHO Drug Information, Vol. 35, No. 4, 2021. Geneva: World Health Organization; 2022. |
Bersiporocin
CAS: 2241808-52-4 F: C15H19Cl2N3O W: 328.24
Bersiporocin is a prolyl-tRNA synthetase inhibitor. Bersiporocin has an IC50 of ≤100 nM for phosphoribosylpyrophosphate
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.